A Brief Introduction to Variant Identification and Analysis

The human genome is highly similar across individuals, yet small differences in DNA sequences account for much of our diversity and influence health and disease¹. These differences, known as variants, occur in many forms and can range from single-base changes to large chromosomal rearrangements.

Types of Variants
Variants can be benign, disease-associated, or of uncertain significance. Studying them helps scientists determine whether a mutation contributes to disease and provides insights into genetic diversity. One of the simplest and most widely studied forms of variation is the single nucleotide variant (SNV), in which one base (A, T, G, or C) is substituted with another. These variants may be rare or common, and when they occur in at least 1% of a population, they are called single nucleotide polymorphisms (SNPs)². Despite involving only a single base, SNVs can have a major impact on gene function and are widely used as genetic markers in research.

Another common type of variation involves insertions and deletions, collectively referred to as indels. These changes can range from a single base to longer DNA segments. Indels may disrupt the reading frame of a gene, producing altered or nonfunctional proteins, and they are especially difficult to detect in repeat-rich regions³. Copy number variations (CNVs) are changes in the number of copies of specific DNA segments, often larger than 1 kilobase. They may involve duplications, which increase copy number, or deletions, which reduce it. CNVs can span individual genes or entire chromosomal regions, altering gene dosage and contributing to genetic diversity and evolution. They are also associated with numerous genetic disorders and with susceptibility to complex diseases. Structural variants (SVs) are large-scale DNA alterations that significantly shape genetic diversity and disease. These include duplications, deletions, inversions, translocations, and complex rearrangements, and their size and complexity make them difficult to detect.

How Variants Are Identified
Scientists detect genomic variants using a range of approaches, with next-generation sequencing (NGS) as the most common. In particular, whole genome and whole exome sequencing provide broad coverage, while targeted capture panels offer faster, more affordable detection of specific variants. Short-read sequencing has been widely applied but struggles in repetitive regions and with large rearrangements. Long-read technologies improve resolution in complex regions and enable the discovery of variants missed by short reads, though higher costs and DNA requirements remain challenges⁴.

Variant calling methods include alignment-based tools (e.g., GATK, Samtools, FreeBayes) that map reads to a reference genome, de novo assembly-based methods (e.g., ABySS, SOAPdenovo) that build genomes from scratch, and hybrid approaches (e.g., FermiKit, Cortex) that combine both strategies⁵. After detection, annotation, and interpretation tools such as ANNOVAR, SnpEff, and VEP assess variant effects on genes, proteins, and populations, while pathway and network tools (e.g., VEA, GENEASE) place findings in a biological context, linking genetic variation to health and disease.

Challenges and Considerations
Variant analysis is complicated by several factors that affect accuracy and interpretation. A major hurdle is detecting variants that occur at very low frequencies within a sample or population. Distinguishing these rare events from sequencing or alignment errors requires deep sequencing and advanced statistical methods. Approaches such as pooled sequencing and molecular barcoding improve sensitivity, making it possible to study rare diseases and expand our understanding of genetic variation. Identifying low-frequency variants is especially important because they may represent pathogenic changes with significant clinical implications.

Certain regions of the genome are inherently difficult to study due to their complexity, often caused by repetitive sequences, segmental duplications, or high GC content. These areas challenge read alignment, variant calling, and interpretation, and frequently require long-read sequencing or specialized computational tools. Detecting structural variants adds further difficulty, as short-read sequencing struggles to capture large genomic rearrangements such as deletions, duplications, inversions, and translocations. To improve accuracy, researchers often combine methods such as read-pair analysis, split-read mapping, and read depth-based strategies. Advances in long-read sequencing are improving the resolution of structural variants and enabling more reliable characterization of complex genomic regions.

Another persistent issue is determining whether detected variants are real or artifacts. Errors introduced during sample preparation or sequencing can create false positives that require additional sequencing to validate. On the other hand, overly strict filtering may cause true rare variants to be missed. Balancing sensitivity and specificity is a constant challenge. Finally, interpretation remains a major obstacle, particularly when dealing with variants of uncertain significance. Determining whether these variants are benign or pathogenic is one of the most difficult aspects of clinical genomics and continues to limit the translation of sequencing data into actionable insights.

Common Applications
There are many important applications for investigating variants. One of the most common is clinical diagnostics, where pathogenic variants are identified to determine the genetic basis of disease. This is especially valuable for diagnosing rare disorders and advancing precision medicine. Cancer genomics is another major area of variant analysis. Detecting driver mutations and tracking additional mutations is essential for developing targeted therapies, classifying tumors, and predicting outcomes.

An emerging application is pharmacogenomics, which uses a person’s genetic information to guide drug selection and dosing. By linking genetic profiles to drug response, pharmacogenomics helps optimize treatment strategies and supports the development of companion diagnostics. Variant analysis also plays a major role in research. In population genetics, it provides insights into genetic diversity, human migration, natural selection, and the basis of complex traits, though large-scale studies must address challenges such as population structure and bias. All together, these applications show how variant analysis translates genetic data into actionable insights, driving progress in both biomedical research and personalized healthcare.

References

1. Collins FS, Mansoura MK. The Human Genome Project. Revealing the shared inheritance of all humankind. Cancer. 2001;91(1 Suppl):221-225. doi:10.1002/1097-0142(20010101)91:1+<221::aid-cncr8>3.3.co;2-0
2. Brookes AJ. The essence of SNPs. Gene. 1999;234(2):177-186. doi:10.1016/s0378-1119(99)00219-x
3. Hu J, Ng PC. Predicting the effects of frameshifting indels. Genome Biol. 2012;13(2):R9. Published 2012 Feb 9. doi:10.1186/gb-2012-13-2-r9
4. Kosugi S, Terao C. Comparative evaluation of SNVs, indels, and structural variations detected with short- and long-read sequencing data. Hum Genome Var. 2024;11(1):18. Published 2024 Apr 17. doi:10.1038/s41439-024-00276-x
5. Zverinova S, Guryev V. Variant calling: Considerations, practices, and developments. Hum Mutat. 2022;43(8):976-985. doi:10.1002/humu.24311